Cargando…

Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus

BACKGROUND: Type 2 diabetes mellitus is associated with chronic low grade inflammation. One of the novel inflammatory markers is hemogram derived neutrophil to lymphocyte ratio (NLR). OBJECTIVE: We aimed to compare NLR levels of diabetic subjects and healthy controls and to observe possible correlat...

Descripción completa

Detalles Bibliográficos
Autores principales: Duman, Tuba T, Aktas, Gulali, Atak, Burcin M, Kocak, Mehmet Z, Erkus, Edip, Savli, Haluk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Makerere Medical School 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531946/
https://www.ncbi.nlm.nih.gov/pubmed/31148989
http://dx.doi.org/10.4314/ahs.v19i1.35
_version_ 1783420910616707072
author Duman, Tuba T
Aktas, Gulali
Atak, Burcin M
Kocak, Mehmet Z
Erkus, Edip
Savli, Haluk
author_facet Duman, Tuba T
Aktas, Gulali
Atak, Burcin M
Kocak, Mehmet Z
Erkus, Edip
Savli, Haluk
author_sort Duman, Tuba T
collection PubMed
description BACKGROUND: Type 2 diabetes mellitus is associated with chronic low grade inflammation. One of the novel inflammatory markers is hemogram derived neutrophil to lymphocyte ratio (NLR). OBJECTIVE: We aimed to compare NLR levels of diabetic subjects and healthy controls and to observe possible correlation between NLR and HbA1c. METHODS: Medical data of type 2 diabetic subjects admitted to out-patient clinics of our institution between April to July in 2017 were obtained from database and retrospectively analyzed. Control group was chosen from healthy subjects who visited our institution for a routine check-up. Anthropometric measures, laboratory data, including, HbA1c, NLR were recorded. RESULTS: Median NLR of the type 2 DM group 2.44 (1.9) was significantly elevated when compared to healthy controls (1.5 (0.9), (p<0.001). In addition, a Pearson's correlation test revealed that NLR was strongly correlated with age (r=0.26, p=0.008), fasting plasma glucose (r=0.38, p<0.001), and HbA1c (r=0.49, p<0.001). CONCLUSION: Elevated NLR in otherwise healthy subjects may be indicative of underlying impaired glucose metabolism and moreover, NLR should be used as a marker of diabetic control level in addition to HbA1c in type 2 diabetic subjects.
format Online
Article
Text
id pubmed-6531946
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Makerere Medical School
record_format MEDLINE/PubMed
spelling pubmed-65319462019-05-30 Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus Duman, Tuba T Aktas, Gulali Atak, Burcin M Kocak, Mehmet Z Erkus, Edip Savli, Haluk Afr Health Sci Articles BACKGROUND: Type 2 diabetes mellitus is associated with chronic low grade inflammation. One of the novel inflammatory markers is hemogram derived neutrophil to lymphocyte ratio (NLR). OBJECTIVE: We aimed to compare NLR levels of diabetic subjects and healthy controls and to observe possible correlation between NLR and HbA1c. METHODS: Medical data of type 2 diabetic subjects admitted to out-patient clinics of our institution between April to July in 2017 were obtained from database and retrospectively analyzed. Control group was chosen from healthy subjects who visited our institution for a routine check-up. Anthropometric measures, laboratory data, including, HbA1c, NLR were recorded. RESULTS: Median NLR of the type 2 DM group 2.44 (1.9) was significantly elevated when compared to healthy controls (1.5 (0.9), (p<0.001). In addition, a Pearson's correlation test revealed that NLR was strongly correlated with age (r=0.26, p=0.008), fasting plasma glucose (r=0.38, p<0.001), and HbA1c (r=0.49, p<0.001). CONCLUSION: Elevated NLR in otherwise healthy subjects may be indicative of underlying impaired glucose metabolism and moreover, NLR should be used as a marker of diabetic control level in addition to HbA1c in type 2 diabetic subjects. Makerere Medical School 2019-03 /pmc/articles/PMC6531946/ /pubmed/31148989 http://dx.doi.org/10.4314/ahs.v19i1.35 Text en © 2019 Duman et al. Licensee African Health Sciences. This is an Open Access article distributed under the terms of the Creative commons Attribution License (https://creativecommons.org/licenses/BY/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Articles
Duman, Tuba T
Aktas, Gulali
Atak, Burcin M
Kocak, Mehmet Z
Erkus, Edip
Savli, Haluk
Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus
title Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus
title_full Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus
title_fullStr Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus
title_full_unstemmed Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus
title_short Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus
title_sort neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531946/
https://www.ncbi.nlm.nih.gov/pubmed/31148989
http://dx.doi.org/10.4314/ahs.v19i1.35
work_keys_str_mv AT dumantubat neutrophiltolymphocyteratioasanindicativeofdiabeticcontrollevelintype2diabetesmellitus
AT aktasgulali neutrophiltolymphocyteratioasanindicativeofdiabeticcontrollevelintype2diabetesmellitus
AT atakburcinm neutrophiltolymphocyteratioasanindicativeofdiabeticcontrollevelintype2diabetesmellitus
AT kocakmehmetz neutrophiltolymphocyteratioasanindicativeofdiabeticcontrollevelintype2diabetesmellitus
AT erkusedip neutrophiltolymphocyteratioasanindicativeofdiabeticcontrollevelintype2diabetesmellitus
AT savlihaluk neutrophiltolymphocyteratioasanindicativeofdiabeticcontrollevelintype2diabetesmellitus